Acute graft-versus-host disease (GVHD) is a disorder involving the skin, gut and liver that is caused by mismatches of major and/or minor histocompatibility antigens between the HLA-identical donor and recipient. If T lymphocytes infiltrating GVHD lesions recognize antigens expressed in these organs, T cell clones should expand in inflammatory tissues. We previously reported that recipients of allogeneic bone marrow grafts have clonally expanded TCR␣␤ + T lymphocytes soon after transplantation, which leads to a skew of TCR repertoires. To establish whether or not the same antigens cause clonal expansion of T lymphocytes in both blood and GVHD tissues, we examined the usage of TCR ␣ and ␤ chain variable regions (TCRAV and TCRBV) and determined the complementarity-determining region 3 (CDR3) of T lymphocytes clonally expanded in circulating blood and GVHD lesions. We found that the repertoires and CDR3 diversity of TCRAV and TCRBV differed between the GVHD lesions and circulating blood, suggesting the selective recruitment of antigenspecific T cells into GVHD tissues. We also found that the usage of TCRAV and TCRBV by the clonally expanded T lymphocytes and their CDR3 sequences differed between the GVHD tissues and blood. These results suggest that the antigen specificity of TCR␣␤ between the donor and recipient.
between the donor and recipient. 1 Although several candidates for minor histocompatibility antigens have been reported, including the male-specific H-Y antigen, cellularly defined minor HA antigens and myxovirus-related protein, the mechanism of cellular injury in acute GVHD has not been fully elucidated. [2] [3] [4] We previously reported a skewing of repertoires of the T cell receptor-␤ chain variable region (TCRBV) and the TCR-␣ chain variable region (TCRAV) in recipients of allogeneic hematopoietic stem cell grafts from HLAmatched donors. 5 This results from the extensive clonal expansion of a limited number of T cells in the graft. 6 Skewed TCR repertoires accompany accumulation of the CD28 Ϫ fraction in both CD4 + and CD8 + T cells. 7, 8 Since accumulating evidence indicates an association between the loss of CD28 expression and T lymphocyte aging, 9, 10 posttransplant skewing of the TCR repertoires probably results from chronic antigen stimulation in vivo.
The above results raise the issue of whether or not clonally expanded T cells in circulating blood recognize the discrepant histocompatibility antigens between donors and recipients, which may be responsible for the induction of acute GVHD. Moreover, crucial questions include whether or not T lymphocytes infiltrating acute GVHD lesions recognize antigens commonly expressed in the skin, gut and liver. To address these questions, we examined the TCR repertoire and complementarity-determining region 3 (CDR3) of T lymphocytes clonally expanded in blood and GVHD lesions from the same individual, since there is accumulating evidence for an association between TCR repertoire restriction and T cell antigen specificity. [11] [12] [13] [14] [15] The CDR3 loops of TCRBV and TCRAV make the principle contacts with the antigenic peptide bound to the MHC molecules and the CDR3 sequences of TCR are crucial predictors of antigen specificity. 16, 17 Here, we demonstrate that the TCR variable region repertoire and CDR3 sequence differ between the T cells clonally expanded in blood and those in GVHD lesions after human allogeneic bone marrow transplantation, and discuss the clinical relevance of our findings. a HLA types were serologically determined in these patients. CML = chronic myelogenous leukemia; CP1 = first chronic phase; AML = acute myelogenous leukemia; CR1 = first complete remission; ALL = acute lymphoblastic leukemia.
Materials and Methods

Patients
Characteristics of the patients included in this study are described in Table 1 . All patients were conditioned with VA011  VA012  VA013  VA014  VA021  VA022  VA023  VA031  VA041  VA042  VA051  VA061  VA071  VA072  VA081  VA082  VA091  VA101  VA111  VA121  VA131  VA141  VA151  VA161  VA171  VA181  VA191  VA201  VA211  VA221  VA231  VA241  VA251  VA261  VA271  VA281  VA291  VA301  VA311  VA321   TCRAV probe   PBMC day 34  Skin  day 36   20   15   10   5   0   % Frequency   VB011  VB021  VB031  VB041  VB051  VB052  VB053  VB054  VB055  VB061  VB062  VB063  VB064  VB065  VB071  VB081  VB082  VB091  VB101  VB111  VB121  VB131  VB132  VB133  VB134  VB141  VB151  VB161  VB171  VB181  VB191  VB201  VB211  VB221  VB231  VB241  VB251   TCRBV probe   PBMC day 34  Skin  day 36 UPN01 Skin a Figure 1 TCRAV and TCRBV repertoires of TCR␣␤ + T lymphocytes expanded in skin (a) and gut (b) GVHD lesions from patient UPN01. Biopsy specimens and blood were collected at the indicated time after transplantation. Open and closed triangles indicate the skewed TCR variable region subfamilies in the blood and GVHD lesion, respectively. VA011  VA012  VA013  VA014  VA021  VA022  VA023  VA031  VA041  VA042  VA051  VA061  VA071  VA072  VA081  VA082  VA091  VA101  VA111  VA121  VA131  VA141  VA151  VA161  VA171  VA181  VA191  VA201  VA211  VA221  VA231  VA241  VA251  VA261  VA271  VA281  VA291  VA301  VA311  VA321   PBMC  Colon   day 104  day 110   TCRAV probe   20   15   10   5   0   % Frequency   VB011  VB021  VB031  VB041  VB051  VB052  VB053  VB054  VB055  VB061  VB062  VB063  VB064  VB065  VB071  VB081  VB082  VB091  VB101  VB111  VB121  VB131  VB132  VB133  VB134  VB141  VB151  VB161  VB171  VB181  VB191  VB201  VB211  VB221  VB231  VB241  VB251   TCRBV total body irradiation and cyclophosphamide, followed by an infusion of allogeneic bone marrow from serologically HLA-matched donors. Cyclosporin and short term methotrexate were administered for prophylaxis of acute GVHD. 18 Acute GVHD was graded according to the criteria of Glucksberg et al. 19 Biopsied specimens from the skin and colon were in part cryopreserved for the following experiment after obtaining written informed consent. The ethics committee of our institution approved the experimental protocol.
Repertoire analysis of TCRAV and TCRBV
TCRAV and TCRBV repertoires were analyzed using an adaptor ligation PCR-based microplate hybridization assay, as described. 20, 21 Briefly, total RNA was extracted from PBMCs and biopsy specimens, and converted to doublestranded cDNA using a SuperScript cDNA synthesis kit (BRL, Bethesda, MD, USA). RNA extraction from skin and colon biopsy specimens embedded in OCT medium was performed according to the method described by Yamamura et al. 22 The P10EA/P20EA adaptors were ligated to the 5Ј end of cDNA, and PCR was performed using either a biotinylated TCRAC (TCR-␣ chain constant region)-specific or a TCRBC (TCR-␤ chain constant region)-spe-cific primer, and a P20EA primer. 23 Biotinylated PCR products were hybridized with immobilized TCRAV-or TCRBV-specific primers in 96-well microtiter plates. Subsequently, alkaline phosphatase-conjugated streptavidin was added to each well and a colorimetric assay was performed. After color development, absorbance was determined at 405 nm and data were directly transferred to a computer for calculation. The optical density (OD) of the wells containing immobilized TCRAV/TCRBV-specific probes was standardized according to the hybridization efficiency of each of them. The corrected OD values were used to calculate the relative frequency of TCRAV/TCRBV usage. The formula is as follows: relative frequency (%) = corrected OD with a TCRAV/TCRBV-specific probe ϫ 100/sum of corrected OD values with TCRAV/TCRBV-specific probes. Skewing of the TCR repertoire was defined as a significant increase of TCRAV and TCRBV subfamilies to an extent that was above the mean percentage plus 3 standard deviations (s.d.) of 20 healthy individuals and which exceeded 5% of total circulating blood T cells. 5 
PCR amplification and CDR3 size distribution analysis of the TCR-␤ chain
Analysis of CDR3 sizes of a given TCR-␤ chain allows the estimation of clonal expansion over a polyclonal back- VA011  VA012  VA013  VA014  VA021  VA022  VA023  VA031  VA041  VA042  VA051  VA061  VA071  VA072  VA081  VA082  VA091  VA101  VA111  VA121  VA131  VA141  VA151  VA161  VA171  VA181  VA191  VA201  VA211  VA221  VA231  VA241  VA251  VA261  VA271  VA281  VA291  VA301  VA311  VA321 TCRAV probe VB011  VB021  VB031  VB041  VB051  VB052  VB053  VB054  VB055  VB061  VB062  VB063  VB064  VB065  VB071  VB081  VB082  VB091  VB101  VB111  VB121  VB131  VB132  VB133  VB134  VB141  VB151  VB161  VB171  VB181  VB191  VB201  VB211  VB221  VB231  VB241  VB251 TCRBV probe PBMC day 52 Skin day 53
PBMC day 52 Skin day 53
Figure 2 TCRAV and TCRBV repertoires of TCR␣␤ + T lymphocytes expanded in skin GVHD lesion from patient UPN02.
Bone Marrow Transplantation ground. 24 We used this technique to determine the clonality of T cells carrying skewed TCRBV subfamilies. Total RNA was extracted from PBMCs isolated from 10 ml of heparinized blood, using an RNeasy Total RNA Kit (Qiagen, Hilden, Germany). Complementary DNA was synthesized using a FirsT Strand cDNA Synthesis Kit with an oligodT primer (Amersham Pharmacia Biotech, Uppsala, Sweden). 25, 26 Aliquots of the cDNA were amplified with a V␤-specific primer and a C␤-specific primer. The sequences of the V␤ and C␤ primers were previously described. 27 PCR amplification proceeded over 40 cycles in a 20 l reaction mixture containing 0.2 m of each primer and 0.5 U of Taq polymerase (TaKaRa, Osaka, Japan). Conditions for the PCR were as follows: denaturation at 94°C for 1 min, annealing at 55°C for 1 min, and extension at 72°C for 1.5 min. Thereafter, a further extension at 72°C for 15 min was added. The PCR buffer was 10 mm TrisHCl (pH 8.3), 50 mm KCl, 1.5 mm MgCl 2 , and 0.2 mm of each dNTP. Aliquots (4 l) of the unlabeled V␤-C␤ PCR products were elongated by one cycle (runoff reaction) with a FAM-labeled nested C␤ primer (FAM-CB3) under the following conditions: denaturation at 94°C for 2 min, annealing at 55°C for 1 min, and extension at 72°C for 15 min. The reaction buffer was the same as that described VA011  VA012  VA013  VA014  VA021  VA022  VA023  VA031  VA041  VA042  VA051  VA061  VA071  VA072  VA081  VA082  VA091  VA101  VA111  VA121  VA131  VA141  VA151  VA161  VA171  VA181  VA191  VA201  VA211  VA221  VA231  VA241  VA251  VA261  VA271  VA281  VA291  VA301  VA311  VA321 TCRBV probe PBMC day 63  Skin  day 63   VB011  VB021  VB031  VB041  VB051  VB052  VB053  VB054  VB055  VB061  VB062  VB063  VB064  VB065  VB071  VB081  VB082  VB091  VB101  VB111  VB121  VB131  VB132  VB133  VB134  VB141  VB151  VB161  VB171  VB181  VB191  VB201  VB211  VB221  VB231  VB241  VB251 UPN03 Skin above. The labeled PCR products were mixed with a size marker (GeneScan-500 TAMRA; Applied Biosystems, Warrington, UK), and loaded on to 5% polyacrylamide sequencing gels for determination of size and fluorescence intensity using an automated DNA sequencer (ABI 377; Perkin-Elmer Applied Biosystems, Foster City, CA, USA). Data were analyzed using GeneScan software (PerkinElmer Applied Biosystems).
DNA sequencing analysis of CDR3 region
PCR products of TCRAV and TCRBV were purified from agarose gels using a Suprec-01 kit (TaKaRa). The purified fragments were ligated to EcoRV sites of a pBluescript II KS-plasmid vector. DH10B cells were transformed with the recombinant plasmid by electroporation. Positive clones were selected by blue/white screening, then cycle sequenced with modified Tth polymerase (SequencePro, Toyobo, Osaka, Japan). 
37,38
b Each value represents percentage of TCRAV/BV subfamily in total TCR␣␤ ϩ T lymphocytes in the indicated samples, which were calculated from data of TCR repertoire analyses. c Junctional sequences found within clonally expanded T cells in both skin and gut lesions of UPN01 are underlined.
Results
Different TCRAV and TCRBV repertoires between GVHD lesions and peripheral blood
We previously reported that skewed TCRAV and TCRBV repertoires of circulating blood T lymphocytes appear soon after allogeneic hematopoietic cell transplantation. 5, 27 To determine whether skewed TCRAV and TCRBV families are also found in GVHD lesions as well as in peripheral blood, we compared the TCR repertoires of T lymphocytes in GVHD tissues with those in PBMCs from the same individual.
In the cutaneous GVHD lesion of patient UPN01, usage of TCRVA8-2, TCRBV13-1 and TCRBV14-1 was increased, whereas the PBMCs showed no skewing of TCR repertoires at the onset of acute cutaneous GVHD ( Figure  1a) . Similarly, the TCRAV and TCRBV repertoires were examined in gut GVHD lesions and in PBMCs, which were collected on days 110 and 104 after transplantation, respectively. In this patient, the skin manifestation of acute GVHD responded to corticosteroid therapy, but tapering of cortico- steroid was accompanied by severe diarrhea exceeding 2 liters a day. Diagnostic colonofiberscopy was performed to confirm the diagnosis of acute gut GVHD. TCRVA4-2, VA6-1, VA8-2, VB6-4 and VB24-1 were skewed in the PBMCs, whereas the usage of TCRVA8-2, VA11-1, VB5-1 and VB6-1 was increased in the gut GVHD lesion. Thus, the skewed TCR subfamilies were not identical between the blood and tissue (Figure 1b) .
We confirmed this finding in two additional patients. In patient UPN02, VA2-1, VA6-1, VA8-2, VA31-1, VB14-1, VB22-1 and VB24-1 were skewed in blood T lymphocytes, whereas the usage of VA2-2, VA4-1, VA6-1, VA21-1, VB12-1 and VB14-1 was increased in skin GVHD tissue (Figure 2) . In patient UPN03, VA3-1, VA14-1, VB15-1 and VB24-1 were skewed in the blood, whereas the usage of VA1-4, VA3-1, VA4-1, VA4-2, VA8-2, VB5-2, VB6-1, VB6-3, VB11-1 and VB16-1 was increased in the skin GVHD lesion (Figure 3) . Again, the skewed TCR variable region subfamilies differed between the blood and GVHD tissue in these two patients.
TCR repertoire diversity in GVHD lesions and identification of homologous CDR3 sequences in skin and gut GVHD lesions
We examined the CDR3 sequences of the T cells expanded in GVHD lesions to determine whether or not the expansion Bone Marrow Transplantation of T lymphocytes was clonal and whether TCR diversity differed between GVHD lesions and blood T cells. The skewing of TCRAV and TCRBV subfamilies in the cutaneous and gut GVHD lesions of patient UPN01 was a result of clonal expansion, as demonstrated by the colony frequency of each clone (Tables 2 and 3 ). TCR repertoire diversity considerably differed between GVHD lesions and PBMCs in agreement with the previous reports. 28, 29 These results suggest that antigen-specific T cell clones are recruited from the blood into the skin and gut tissues, resulting in clonal expansion. We identified homologous amino acid sequences in the CDR3 regions of the skewed TCRAV and TCRBV subfamilies in the skin and gut GVHD lesions from this particular patient. We detected the deduced amino acid sequence -E-N-I-in the CDR3 regions of TCRAV8S2 in the skin and in TCRAV8S2 in the colon (Tables 2 and 3 ). These two clones were independent, since the entire junctional sequences and TCRAJ segments were different. In addition, the sequences -G-L-A-and -A-G-Swere found in the CDR3 regions of TCRBV6S1 and TCRBV5S1 respectively, in the colon, and the -G-L-A-G-S-sequence that includes both -G-L-A-and -A-G-S-, was found in the CDR3 regions of TCRBV14S1 in the skin.
We also examined the clonality of the T cells expanding in the skin GVHD lesion in patients UPN02 and UPN03. We confirmed the clonal expansion of T cells carrying TCRVA2-2, VA21-1, VB12-1 and VB14-1 in the GVHD lesion of patient UPN02 (Table 4) . Comparing the CDR3 diversity of T cells in the GVHD tissue with that in blood, T cells carrying TCRVA2-2 and VB14-1 were clonally expanded in both the GVHD tissue and blood, and the CDR3 diversity appeared to be equal. In contrast, expansion of the T cell clone using TCRVB12-1 with the -G-L-A-CDR3 sequence was only identified in the GVHD tissue and the CDR3 diversity was quite limited compared with that of blood T lymphocytes. The magnitude of the T cell expansion, which is expressed as the difference in % frequency between the skin and blood, appears to predict the clonality, suggesting that extensive proliferation results in contracted CDR3 diversity. The -G-L-A-sequence was not found in the CDR3 region of clonally expanded T lymphocytes in the skin GVHD lesion of patient UPN03, who did not have an HLA-A2 antigen (Table 5) .
Different usage of TCRBV subfamily and CDR3 sequence in T lymphocytes clonally expanded in blood and GVHD tissues
As described above, we reported that TCR␣␤ + T lymphocytes clonally expand in blood after human allogeneic hem- Table 4 Deduced amino acid sequences of CDR3 regions of TCRs preferentially used by T cells infiltrating cutaneous GVHD lesions from UPN02 a Diagnostic skin biopsy was performed on day 53. b Each value represents percentage of TCRAV/BV subfamily in total TCR␣␤ ϩ T lymphocytes in the skin lesion. c Junctional sequence that was also found in clonally expanded T cells in the skin lesion from patient UPN01 is underlined. d Frequency of TCRBV12S2 usage by peripheral blood T lymphocytes was 1.3% in a skin biopsy from this patient on day 53. atopoietic stem cell transplantation. 5, 6 To address whether or not the clonally expanded T cells in circulating blood recognize the same antigen as those expanded in GVHD lesions, we compared the usage of TCRAV and TCRBV subfamilies and the CDR3 sequences of clonally expanded T cells from blood and tissues. Since expanded T cells in the blood were not necessarily clonal/oligoclonal, 6 clonality was first determined by TCRBV-CDR3 size spectratyping (Figure 4) , then the CDR3 sequences of clonally expanded T cells were analyzed. Table 6 shows that usage of the TCRBV subfamily by T cells clonally expanded in the blood and the structure of CDR3 of those lymphocytes differed from those of T lymphocytes expanded in GVHD tissues.
Discussion
We recently reported the post-transplant skewing of TCR repertoires, as a result of the oligoclonal expansion of CD8 + CD28 Ϫ T cells. 5, 7 In addition, evidence indicates the stable clonal expansion of T lymphocytes after bone marrow transplantation. 30, 31 Whether these clonally expanded T cells in blood recognize allogeneic, or microorganism-921 Table 5 Deduced amino acid sequences of CDR3 regions of TCRs preferentially used by T cells infiltrating cutaneous GVHD lesions from UPN03 Bone Marrow Transplantation derived antigens remains uncertain. However, the distinct usage of TCRAV and TCRBV subfamilies and the different CDR3 sequences between T lymphocytes infiltrating GVHD lesions and blood T cells suggest that the antigen specificity of T cells that clonally expanded in blood and GVHD lesions is different. However, because of the lack of evidence that T lymphocytes with a given CDR3 motif have a defined antigen specificity, the biological significance of distinct TCR variable region repertoire and CDR3 sequences of clonally expanded T lymphocytes in blood and GVHD lesions remains speculative. We identified distinct TCR␣␤ + T cell clones with the same TCRAV segment and homologous CDR3 sequences that expanded in skin and gut lesions of acute GVHD from the same individual (UPN01), suggesting the presence of antigens commonly expressed in the skin and gut responsible for inducing acute GVHD. We also found three amino acid sequence homology in TCR-␤ CDR3 regions of T cells expanded in skin and gut, although the usage of TCRBV segments was different (Tables 2 and 3 ). However, no evidence suggests that clonally expanded T lymphocytes in the GVHD lesions use the TCR␣-chain carrying the -ENIsequence paired with the TCR␤-chain having either the -GLA-or -AGS-sequence.
Whether any shared minor histocompatibility antigens Tables 2 to 4 show that the deduced amino acid sequence -G-L-A-was identified in the CDR3 region of an expanded T cell clone carrying TCRBV12S2 from patient UPN02, and that this was also found in the skin and gut GVHD lesions of patient UPN01. In contrast, in the patient without HLA-A2 antigen, these sequences were not found in the CDR3 region of clonally expanding T cells in the skin GVHD lesion (Table  5 ). Since HLA allele typing has not been performed in these patients, there is no definitive evidence for a dominant role for minor histocompatibility antigens in the recruitment and expansion of T cell clones in GVHD tissues. There is a report describing that chronic antigen stimulation causes limited TCRBV usage and highly conserved CDR3 sequences between distinct individuals, using an MHC/A2-restricted EBV-derived peptide tetramer technique. 34 It has been also demonstrated that CDR3 sequence homology only exists for T cells using the same TCRBV segment. 34 TCRBV segments used by T cell clones in GVHD skin lesions were different between patients UPN01 and UPN02. Therefore, whether or not shared minor histocompatibility antigens are involved in the development of acute GVHD is still an open question.
The crucial question that remains to be determined in human allogeneic hematopoietic cell transplantation is whether the minor histocompatibility antigens responsible for GVHD and GVL are the same or different. 35 One of the major obstacles to answering this question is the difficulty of identifying T cell clones that are specific for leukemia-associated antigens in vivo. DLI or nonmyeloablative hematopoietic stem cell transplantation may provide situations where such T cell clones can be identified in vivo, since large numbers of mature T cells are infused to patients and T cell responses may be augmented. 36 However, the present study suggests that clonal expansion of peripheral blood T lymphocytes does not necessarily reflect the T cell response against leukemia-related antigens, and that the data obtained from circulating blood T cells should be carefully interpreted. Nevertheless, a structural analysis of the TCR used by T cell clones that are reactive against leukemia and which expand in vivo may provide insights into a better understanding of the mechanisms of GVHD and GVL.
